The Institute of Pharmaceutical Innovation

IPI Seminar Series

All welcome to attend

All seminars will take place in Conference Room 2.11 of the IPI building at 2pm.

Event Date(s)

Wednesday 19th March, 2008 - Wednesday 22nd October, 2008

Event Objectives

March 19th
Professor Alan Windle, University of Cambridge and Director of the Pfizer
Institute for Pharmaceutical Materials Science.
“Aspects of Pharmaceutical Materials Science”

Professor Windle holds the chair of Materials Science in the University of Cambridge and was Head of the Department of Materials Science and Metallurgy until the end of 2000. He has recently completed two years as Executive Director of the Cambridge-MIT Institute.

April 16th
Professor Mojtaba Ghadiri, University of Leeds.
“Dispersion of Cohesive Powder for Dry Powder Inhalation”

Professor Ghadiri is director of the Institute of Particle Science & Engineering and Professor of Chemical Engineering at the University of Leeds.

May 28th
Dr Rob Price, University of Bath
“The influence of crystals, particles and powders on inhaled systems”

Dr Price’s interests focus on investigating the physicochemical properties which govern inter-particulate adhesion, issues relating to the surface stability of processed particles and the general areas of particle technology and crystal growth.

June 18th
Professor Duncan Craig, Head of Pharmacy University of East Anglia.

Professor Craig is head of Pharmacy, School of Chemical Sciences and Pharmacy at the University of East Anglia. His research focusses on the study of drug delivery systems, developing dielectric analysis as a novel pharmaceutical tool, working in collaboration with Professor Robert Hill (Department of Physics and Mathematics, Kings College, University of London).

September 3rd
Dr Ihtesham Ur Rehman of Queen Mary London.
“Diagnosing Cancer with Spectroscopy”.

Dr. Rehman is Reader in Biomedical Materials at Materials Department/IRC in Biomedical Materials, Queen Mary, University of London and has been working in this field since 1987. His research work includes synthesis of polymers, formation of nano-bioceramics and impregnation of drugs in polymers for controlled drug delivery applications, and spectroscopic analysis of biological tissues.

His current research involves the use of Raman and FTIR spectroscopy techniques to characterise cancer tissues, cancer cell lines and compare these with natural tissue. This work is helping a great deal in understanding the chemical changes that occur in the cell during the formation of cancer and also these techniques have been employed to study the effect of chemotherapeutic drugs on cancer cells.

October 22nd
Dr Graham Lappin, head of research and development at Xceleron, York
“Accelerator Mass Spectrometry: An Unlikely Alliance Between Biomedicine and Archaeology”

The talk will consider the impact of a technique known as Accelerator Mass Spectrometry (AMS), previously used primarily for archaeological radiocarbon dating, in the area of biopharmaceutics.

Event Agenda

Registration Details